Verified Treatment Center
San Francisco General Hospital Opiate Treatment Outpatient Program
San Francisco, CA · 94110
Key Takeaways for San Francisco General Hospital Opiate Treatment Outpatient Program
- • Outpatient · MAT · Dual Dx offered
- • Accepts Medicaid
- • SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About San Francisco General Hospital Opiate Treatment Outpatient Program
Located in San Francisco, CA, San Francisco General Hospital Opiate Treatment Outpatient Program operates within the CA regulatory framework as a licensed addiction-treatment provider. The facility offers a continuum of care across multiple levels — Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.
Care levels at San Francisco General Hospital Opiate Treatment Outpatient Program
The facility offers a continuum of care across multiple levels — Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care San Francisco General Hospital Opiate Treatment Outpatient Program provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.
Insurance and payment
San Francisco General Hospital Opiate Treatment Outpatient Program accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.
Specialty programming
The facility's documented specialty programming includes: Pregnant/postpartum women, Clients with HIV or AIDS. Clinical verification of specialty programming should encompass credentialed staff profile, programming-hour documentation, and specialty-specific medical-necessity documentation for third-party authorization. The MHPAEA 2024 rule addresses specialty-program network adequacy for patients requiring specific clinical capabilities.
Before you call
Pre-admission documentation for San Francisco General Hospital Opiate Treatment Outpatient Program should include ASAM-framework level-of-care justification, plan-specific Verification of Benefits with network-contract confirmation, written MAT policy for opioid use disorder patients where applicable, and licensure/accreditation verification. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
San Francisco General Hospital Opiate Treatment Outpatient Program at a Glance
Levels of care
Outpatient · MAT · Dual Dx
Service settings
Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment
Therapy approaches
Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling
Age groups
Young Adults, Adults
Special populations
Pregnant/postpartum women, Clients with HIV or AIDS
Medications
Acamprosate (Campral®), Disulfiram, Methadone, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable)
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.
Contact & Location
Address
1001 Potrero Avenue, San Francisco, CA 94110
Facility direct line
628-206-8412Website
dsaam.org